![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Identa Corp (QB) | USOTC:IDTA | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.28 | 45.90% | 0.89 | 0.41 | 1.00 | 0.89 | 0.89 | 0.89 | 100 | 18:46:12 |
Mr. Shoham stated, "We have been informed by Mr. Mervin Klein, IDenta's contact person to the DOD test for the explosive identifiers, that the US Department of Defense (DOD) has completed testing of our kits. The final reports have been sent to the top officials for review and recommendations."
The following e-mail IDenta has received from Mr: Mervin Klein:
I am in contact with that department on a regular basis. They completed the report and all sent to the higher officials for review before publishing. Per my feedback from the Lab, it's looking good for us. Will advise you as soon as know more. Best rgds. Mervin.
IDenta will report on the results as soon as they become available.
Also, we are in the process of finishing the development of the "blister type" packaging for the introduction of the new General Screening test kit into the drug store chain in 2011. We will release the name of the store chain when we are permitted to do so."
Information concerning IDenta's entire product line may be found at www.IDenta.biz and www.identa-corp.com.
ABOUT IDENTA
Since 2003, IDenta Corporation has been recognized as a worldwide leader in the development of proprietary on-site drug, drug precursor and explosive detection kits. IDenta develops, manufactures and distributes products for both the professional and civil markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world.
DISCLAIMER
Certain of the statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.
For Investor Relations, lobbying interests or information concerning IDenta's products internationally or the development of new chemical detectors, contact: Yaacov Shoham, IDenta Corp., CEO, Tel: +972-52-6554487, fpi@drugsdetector.com, www.identa.biz. www.identa-corp.com
Contact: Yaacov Shoham IDenta Corp. CEO Tel: +972-52-6554487 fpi@drugsdetector.com http://www.identa.biz
1 Year Identa (QB) Chart |
1 Month Identa (QB) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions